|
(MoneyNewsWire.Net, October 18, 2017 ) Middle East and Africa Checkpoint Inhibitors Market was worth USD 610 million in 2016 and is expected to reach USD 1590 million by 2021 with a CAGR of 27.19 %.
Checkpoint Inhibitors Industry are drugs used in Immunotherapy. They are generally made up of antibodies that lead an immune system attack on cancer cells. T-cells launches an attack when it detects infected or Cancerous. Immune system uses a series of molecules called checkpoint molecules to protect normal cells from attack. Cancer cells use these Checkpoints to escape T-cells by arraying themselves with Normal Cells. Checkpoint Inhibitors block these proteins on cancer cells which lets T-Cells launch an attack on Cancer cells.
View Full Report @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-checkpoint-inhibitors-market-2182/
Increasing funding and government support towards developing new drugs and rising Prevalence of cancer globally are some of the factors driving the growth of the market. However, high R&D expense activities is one of the major factors responsible for restricting the growth of the market.
Middle East and Africa Checkpoint Inhibitors Market is categorized based on Drug type and Application. Based on Drug type, market is segmented into PD-L1 inhibitors, PD-1 inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell, and Others. Based on Application, the market is segmented into Lung cancer, Blood cancer, Renal cancer, Bladder Cancer, Melanoma, Hodgkin lymphoma, others. CTLA-4 segment holds the largest share accounting for almost 94 % of the overall market.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-checkpoint-inhibitors-market-2182/request-sample
However, this segment is expected to drop some of its market share to PD-1 inhibitors segment during the mentioned period as majority of new treatments are based on PD-1 inhibitors. Geographically, market is further segmented into Middle East and Africa
Some of the major players in the Middle east and Africa checkpoint inhibitors market include Merck & Co., Inc., Roche, AstraZeneca, Bristol-Myers Squibb, Ono Pharmaceutical Co., Ltd., Novartis International AG, Juno Therapeutics, and Kite Pharma.
Market Segmentation
1) Drug Type
Introduction
PD-1 inhibitors
PD-L1 inhibitors
CTLA-4
Chimeric Antigen Receptor T-cell
Others
Y-o-Y Growth Analysis, By Drug Type
Market Attractiveness Analysis, By Drug Type
Market Share Analysis, By Drug Type
2) Application
Introduction
Lung cancer
Renal cancer
Blood cancer
Bladder Cancer
Hodgkin lymphoma
Melanoma
Others
Y-o-Y Growth Analysis, By Application
Market Attractiveness Analysis, By Application
Market Share Analysis, By Application
Inquire before Buying at http://www.marketdataforecast.com/market-reports/middle-east-and-africa-checkpoint-inhibitors-market-2182/inquire
Reasons to buy Middle East and Africa Checkpoint Inhibitors Market Research Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
